newsfilter
← Latest News
GlobeNewswire·

Interim results for the six months ended June 30, 2026

September 11, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") Interim results for the six months ended June 30, 2026 Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage